| Recent dyslipidemia guidelines for patients with diabetes mellitus |
|
Eun-Jung Rhee 
|
| Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea |
Correspondence
Eun-Jung Rhee ,Tel: +82-2-2001-2485, Email: hongsiri@hanmail.net
|
|
Submitted: June 30, 2020 Accepted after revision: August 17, 2020 |
|
|
| Abstract |
|
Treatment of diabetic dyslipidemia is important for the prevention of cardiovascular diseases in patients with diabetes. Although glucose control is the main target in patients with diabetes mellitus (DM) to prevent diabetic complications, multifactorial interventions are absolutely important to reduce the risk of cardiovascular diseases. Recent joint guidelines from the European Society of Cardiology and European Society for the Study of Diabetes have recommended lower low-density lipoprotein cholesterol (LDL-C) targets for patients with DM and included DM duration in the stratification of risk groups for cardiovascular disease prevention, emphasizing higher cardiovascular risk in patients with DM. In addition, the American Heart Association/American College of Cardiology guidelines were revised so that the LDL-C cutoff appeared in the guidelines for high risk groups and for changes in treatment options. The Korean Diabetes Association also released new treatment guidelines for patients with DM and adopted recent changes from other guidelines with respect to dyslipidemia control. In this review, I examined recent updates in the guidelines for dyslipidemia treatment for patients with DM. |
| Keywords:
Diabetes mellitus; Dyslipidemias; Guideline |
|
PDF Links
Full text via DOI
Download Citation
CrossRef TDM
E-Mail
